Qiagen NV

NYSE:QGEN 4:00:00 PM EDT

39.47

+0.24 (+0.61%)

4:23:42 PM EDT: $39.69 +0.22 (+0.55%)

Market Cap (Intraday)	8.74B
Current PE	25.60
Forward PE	18.8
2yr Forward PE	17.16

See more stats

Estimates Current Quarter

Revenue	$454 Million
Adjusted EPS	$0.44

See more estimates

10-Day MA	$40.34
50-Day MA	$42.87
200-Day MA	$43.45

See more pivots

Qiagen NV Stock, NYSE:QGEN

Hulsterweg 82, Venlo, Limburg 5912 PL

Netherlands

Phone: +31.77.355.66.00

Number of Employees: 5967

http://www.qiagen.com

Description

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.